Treatment of Hepatitis C: Don’t Put All Your Eggs in One Basket!
- 30 April 2007
- journal article
- editorial
- Published by Elsevier in Gastroenterology
- Vol. 132 (4) , 1611-1615
- https://doi.org/10.1053/j.gastro.2007.03.014
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 NonrespondersGastroenterology, 2007
- Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized StudyGastroenterology, 2006
- Nucleoside Analog Inhibitors of Hepatitis C Virus ReplicationInfectious Disorders - Drug Targets, 2006
- Antiviral efficacy of NS3‐serine protease inhibitor BILN‐2061 in patients with chronic genotype 2 and 3 hepatitis C†‡Hepatology, 2005
- Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patientsGastroenterology, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003Hepatology, 2004
- National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10-12, 2002Hepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001